Abstract
Friedreich ataxia (FRDA) is a rare autosomal recessive hereditary disorder that affects approximately 1 in 50,000 Caucasians. It is caused by hyperexpansion of GAA repeats in the first intron of the frataxin gene. Initial symptoms of FRDA usually appear around the beginning of the second decade of life. In addition to neuropathological disabilities such as ataxia, sensory loss, and muscle weakness, common signs are scoliosis, foot deformity, and hypertrophic cardiomyopathy. Approximately 10 % of patients with FRDA develop diabetes. The neuronopathy in the dorsal root ganglia, accompanied by the loss of peripheral sensory nerve fibres and the degeneration of posterior columns of the spinal cord, is a hallmark of the disease and is responsible for the typical combination of signs and symptoms specific to FRDA. Variation in neurophysiological abnormalities is correlated with the size of the GAA repeat expansion and likely accounts for individual variation in the progression of FRDA. Despite a range of disease severity, most patients will lose their ability to walk, stand, or sit without support within 10 to 15 years of disease onset. In addition to a review of the clinicopathological features of FRDA, a discussion of recent advances in our understanding of the underlying molecular mechanisms is provided.
Article PDF
Similar content being viewed by others
Avoid common mistakes on your manuscript.
References
Friedreich N (1863) Über degenerativeAtrophie der spinalen Hinterstränge.Virchows Arch Pathol Anat 26:391–419
Pandolfo M (2006) Friedreich’s ataxia(chapter 17). In Wells RD, Ashizawa(eds) Genetic Instabilities and NeurologicalDiseases, Burlington, Massachusetts,Academic Press, pp 277–296
Harding AE (1981) Friedreich’s ataxia:a clinical and genetic study of 90 familieswith an analysis of early diagnosticcriteria and intrafamilial clustering ofclinical features. Brain 104:589–620
Campuzano V, Montermini L, MoltòMD, Pianese L, Cossée M, Cavalcanti F,et al. (1996) Friedreich’s ataxia: autosomalrecessive disease caused by anintronic GAA triplet repeat expansion.Science 271:1423–1427
Corben LA, Georgiou-Karistianis N,Fahey MC, Storey E, Churchyard A,Horne M, Bradshaw JL, Delatycki MB(2006) Towards an understanding ofcognitive function in Friedreich ataxia.Brain Res Bull 70:197–202
Koeppen AH (2002) Neuropathologyof the inherited ataxias (chapter 25). InManto M, Pandolfo M, editors. TheCerebellum and Its Disorders, NewYork, Cambridge University Press,pp 387–405
Santoro L, De Michele G, Perretti A,Crisci C, Cocozza S, Cavalcanti F,Ragno M, Monticelli A, Filla A, CarusoG (1999) Relation between trinucleotideGAA repeat length and sensoryneuropathy in Friedreich’s ataxia. JNeurol Neurosurg Psychiatry 66:93–96
Santoro L, Perretti A, Lanzillo B,Coppola G, De Joanna G, Manganelli F,Cocozza S, De Michele G, Filla A,Caruso G (2000) Influence of GAA expansionsize and disease duration oncentral nervous system impairment inFriedreich’s ataxia: contribution to theunderstanding of the pathophysiologyof the disease. Clin Neurophysiol 111:1023–1030
Della Nave R, Ginestroni A, GiannelliM, Tessa C, Salvatore E, Salvi F, DottiMT, De Michele G, Piacentini S,Mascalchi M (2008) Brain structuraldamage in Friedreich’s ataxia. J NeurolNeurosurg Psychiatry 79:82–85
Della Nave R, Ginestroni A, Tessa C,Salvatore E, Bartolomei I, Salvi F, DottiMT, De Michele G, Piacentini S,Mascalchi M (2008) Brain white mattertracts degeneration in Friedreichataxia: an in vivo MRI study usingtract-based spatial statistics and voxel-basedmorphometry. Neuroimage 40:19–25
Schapira A, Lodi R (2004) Assessmentof in vitro and in vivo mitochondrialfunction in Friedreich’s ataxia andHuntington’s disease. Methods MolBiol 277:293–307
Gilman S, Junck L, Markel DS, KoeppeRA, Kluin KJ (1990) Cerebral glucosehypermetabolism in Friedreich’s ataxiadetected with positron emission tomography.Ann Neurol 28:750–757
Casazza F, Morpurgo M (1996) Thevarying evolution of Friedreich’s ataxiacardiomyopathy. Am J Cardiol 77:895–898
Chamberlain S, Shaw J, Rowland A,et al. (1988) Mapping of mutation causingFriedreich’s ataxia to human chromosome9. Nature 334:248–250
Jiralerspong S, Liu Y, Montermini L,Stifani S, Pandolfo M (1997) Frataxinshows developmentally regulatedtissue-specific expression in the mouseembryo. Neurobiol Dis 4:103–113
Koutnikova H, Campuzano V, Foury F,Dollé P, Cazzalini O, Koenig M (1997)Studies of human, mouse and yeasthomologues indicate a mitochondrialfunction for frataxin. Nat Genet 16:345–351
Cossée M, Schmitt M, Campuzano V,Reutenauer L, Moutou C, Mandel J-L,Koenig M (1997) Evolution of theFriedreich’s ataxia trinucleotide repeatexpansion: founder effect and premutations.Proc Natl Acad Sci USA 94:7452–7457
Cossée M, Dürr A, Schmitt M, et al.(1999) Frataxin point mutations andclinical presentation of compoundheterozygous Friedreich ataxiapatients. Ann Neurol 45:200–206
Beauchamp M, Labelle H, Duhaime M,Joncas J (1995) Natural history ofmuscle weakness in Friedreich’s ataxiaand its relation to loss of ambulation.Clin Orthop 311:270–275
Montermini L, Richter A, Morgan K,Justice CM, Julien D, Castellotti B,Mercier J, Poirier J, Capozzoli F,Bouchard JP, Lemieux B, Mathieu J,Vanasse M, Seni MH, Graham G,Andermann F, Andermann E, MelançonSB, Keats BJ, Di Donato S, PandolfoM (1997) Phenotypic variability inFriedreich ataxia: role of the associatedGAA triplet repeat expansion. AnnNeurol 41:675–682
Filla A, De Michele G, Cavalcanti F,Pianese L, Monticelli A, Campanella G,Cocozza S (1996) The relationshipbetween trinucleotide (GAA) repeatlength and clinical features in Friedreichataxia. Am J Hum Genet 59:554–560
Giacchetti M, Monticelli A, De Biase I,Pianese L, Turano M, Filla A, DeMichele G, Cocozza S (2004) MitochondrialDNA haplogroups influencethe Friedreich’s ataxia phenotype.J Med Genet 41:293–295
Labuda M, Labuda D, Miranda C,Poirier J, Soong B-W, Barucha NE,Pandolfo M (2000) Unique origin andspecific ethnic distribution of theFriedreich ataxia GAA expansion.Neurology 54:2322–2324
Pianese L, Cavalcanti F, De Michele G,et al. (1997) The effect of parentalgender on the GAA dynamic mutationin the FRDA gene. Am J Hum Genet60:460–463
Montermini L, Kish SJ, Jiralerspong S,Lamarche JB, Pandolfo M (1997)Somatic mosaicism for the Friedreich’sataxia GAA triplet repeat expansionsin the central nervous system. Neurology49:606–610
De Biase I, Rasmussen A, Endres D,Al-Mahdawi S, Monticelli A, Cocozza S,Pook M, Bidichandani SI (2007) ProgressiveGAA expansions in dorsalroot ganglia of Friedreich’s ataxiapatients. Ann Neurol 61:55–60
Zühlke CH, Dalski A, Habeck M,Straube K, Hedrich K, Hoeltzenbein M,Konstanzer A, Hellenbroich Y,Schwinger E (2004) Extension of themutation spectrum in Friedreich’sataxia: detection of an exon deletionand novel missense mutations. Eur JHum Genet 12:979–982
Cavadini P, Gellera C, Patel PI, Isaya G(2000) Human frataxin maintainsmitochondrial iron homeostasis inSaccharomyces cerevisiae. Hum MolGenet 9:2523–2530
Wells RD (1996) Molecular basis ofgenetic instability of triplet repeats.J Biol Chem 271:2875–2878
Ohshima K, Kang S, Larson JE, WellsRD (1996) Cloning, characterization,and properties of seven triplet repeatDNA sequences. J Biol Chem 271:16773–16783
Bidichandani SI, Ashizawa T, Patel PI(1998) The GAA triplet-repeat expansionin Friedreich ataxia interfereswith transcription and may be associatedwith an unusual DNA structure.Am J Hum Genet 62:111–121
Jain A, Rajeswari MR, Ahmed F (2002)Formation and thermodynamic stabilityof intermolecular (R·R·Y) DNAtriplex in GAA/TTC repeats associatedwith Friedreich’s ataxia. J BiomolStruct Dyn 19:691–699
Ohshima K, Montermini L, Wells RD,Pandolfo M (1998) Inhibitory effects ofexpanded GAA·TTC triplet repeatsfrom intron I of the Friedreich’s ataxiagene on transcription and replicationin vivo. J Biol Chem 273:14588–14595
Grabczyk E, Usdin K (2000) TheGAA·TTC triplet repeat expanded inFriedreich’s ataxia impedes transcriptionelongation by T7 RNA polymerasein a length and supercoil dependentmanner. Nucleic Acids Res 28:2815–2822
Gacy AM, Goellner GM, Spiro C, ChenX, Gupta G, Bradbury EM, Dyer RB,Mikesell MJ, Yao JZ, Johnson AJ,Richter A, Melançon SB, McMurray CT(1998) GAA instability in Friedreich’sataxia shares a common, DNA-directedand intraallelic mechanism with othertrinucleotide diseases. Mol Cell 1:583–593
Potaman VN, Oussatcheva EA,Lyubchenko YL, Shlyakhtenko LS,Bidichandani SI, Ashizawa T, SindenRR (2004) Length-dependent structureformation in Friedreich ataxia (GAA)n·(TTC)n repeats at neutral pH. NucleicAcids Res 32:1224–1231
Janssen S, Cuvier O, Müller M,Laemmli UK (2000) Specific gain- andloss-of-function phenotypes inducedby satellite-specific DNA-bindingdrugs fed to Drosophila melanogaster.Mol Cell 6:1013–1024
Saveliev A, Everett C, Sharpe T, WebsterZ, Festenstein R (2003) DNA tripletrepeats mediate heterochromatinprotein-1-sensitive variegated genesilencing. Nature 422:909–913
Herman D, Jenssen K, Burnett R,Soragni E, Perlman SL, Gottesfeld JM(2006) Histone deacetylase inhibitorsreverse gene silencing in Friedreich’sataxia. Nat Chem Biol 2:551–558
Rai M, Soragni E, Jenssen K, Burnett R,Herman D, Coppola G, Geschwind DH,Gottesfeld JM, Pandolfo M (2008)HDAC inhibitors correct frataxin deficiencyin a Friedreich ataxia mousemodel. PLoS ONE 3:e1958
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Pandolfo, M. Friedreich ataxia: The clinical picture. J Neurol 256 (Suppl 1), 3–8 (2009). https://doi.org/10.1007/s00415-009-1002-3
Issue Date:
DOI: https://doi.org/10.1007/s00415-009-1002-3